Healthcare Incentive Decisions Resurface in Audits and Diligence

April 14, 2026

This Comes Back Later in Audits and Diligence

Hal Katz, Jonathan Porter Husch Blackwell LLP + Follow Contact LinkedIn Facebook X Send Embed This is the fifth in a six-part series on incentive design, deal structure, and how these issues surface in transactions and enforcement. Other relevant topics will be discussed in our upcoming presentation, Physician Owner Mindset, Compliance Guardrails: Growth Without the Gotchas, to be given at the American Alliance of Orthopaedic Executives on Tuesday, April 21. Incentive decisions come back. Audits, partner issues, payer questions, and deals.

The original decision may have been reasonable. The problem is that the context is gone. The people who approved it may not be there. The emails are sitting in a folder no one remembers. The spreadsheet still exists.

Then someone asks for the file.

Where the Second Look Comes From

The second look usually comes from one of four places:

• A payer challenges billing, medical necessity, or site of service.
• A partner dispute forces a review of compensation and distributions.
• A compliance review or audit tests arrangements and payments.
• A buyer diligence team asks for anything tied to physician economics. They do not start with the business rationale. They do not assume intent. They read the documents and build from there.

If the documents are thin, inconsistent, or hard to follow, the reviewer fills gaps with risk.

What Reviewers Ask For

When a reviewer does not have the history, they go straight to a short list.

They want to see:

• The written compensation plan and any amendments.
• The formula inputs and any manual adjustments.
• Committee approvals and minutes.
• Ownership agreements and distribution waterfalls.
• Management agreements and fee support.
• Any valuation work and updates.
• Internal communications that explain purpose and expected behavior. It is what ends up mattering when the question becomes, “Why was this paid, and what was it meant to influence?”

Why This Creates Deal Risk

In a transaction, diligence teams map economics.

They trace who gets paid.
They trace how pay changes.
They trace who has control over downstream revenue.

They also assess earnings quality.

If incentive payments are inconsistent, hard to explain, or sensitive to volume in ways that raise questions, buyers respond in predictable ways.

• They widen diligence.
• They ask for more documents.
• They add representations that are hard to sign without qualification.
• They increase escrows or holdbacks.
• They treat risk as a pricing issue. Even when the issue is manageable, it can slow a process down. It can also shift negotiating leverage.

Common Ways Incentive Decisions Resurface

The same patterns come up.

Discretion without a record

Many groups use discretionary payments.

The risk arises when there is no consistent record of:

• Who approved it.
• What criteria were applied.
• What business purpose supported it.
• How it was calculated. If a payment exists and the file is thin, the payment comes into question.

One-off fixes that become permanent

Groups often adjust compensation to solve a short-term issue.

A recruiting gap.
A service line ramp.
A temporary coverage burden.

Those fixes can make sense. They become a problem when they persist without review. Reviewers then treat the exception as the real plan.

Different stories for the same payment

In partner disputes and audits, inconsistencies matter.

If one email says a payment was meant to reward growth, another says it was meant to reward routing, and a third says it was to keep someone from leaving, the organization loses control of the narrative.

Ownership and compensation layered together

In orthopedics, physicians often have more than one economic interest.

Practice compensation.
ASC distributions.
Hospital joint venture distributions.
Management company economics.
Vendor relationships.

Layered economics are not the problem. They become hard to defend when the group cannot show clear separation between clinical decisions and financial results.

What Holds Up Later

The groups that hold up later tend to do a few things consistently.

Document purpose at the time of the decision

Not months later. Not during diligence.

A simple memo or committee record that states:

• What the payment is.
• What it is for.
• How it is calculated.
• Who approved it.
• What data supports it. This is not for the file. It is for the next reviewer.

Keep changes controlled

Compensation plans change. Ownership structures change. Management fees change.

The question is whether changes are:

• Documented.
• Approved through a consistent process.
• Supported by clear records.
• Reviewed periodically. When changes occur informally, the organization cannot easily explain what happened and why.

Refresh valuation and fee support

Valuation work is often done once and then filed away.

In practice, economics change. Service levels change. Scope changes. Volume changes. Ownership changes.

A stale valuation record becomes a weakness during diligence.

Assume your materials will be read cold

This is the right test.

If a buyer, payer, or auditor reads the file without context, can they understand it quickly? Can they see a consistent purpose and approval trail? Can they follow the money?

If the answer is no, the reviewer takes a conservative view. That view appears in price, terms, or scrutiny.

Closing Observation

Incentive decisions create a record. That record outlives the people who made the decision.

Most problems in audits and diligence come from gaps. The economics may be defensible. The file often is not.

[View source.]

Send Print Report

Related Posts

• The Call You Hope Never Comes (and the Emails That Trigger It)
• The Productivity Trap in Comp Plans

Latest Posts

• OSHA Launches New CARE Initiative to Enhance Employer Compliance Support
• Changes in Federal Policy Addressing Student Discipline
• The Data Center Reckoning Is Coming to Your State: Wisconsin Just Showed You What It Looks Like See more »

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.

©
Husch Blackwell LLP

Written by:

Husch Blackwell LLP Contact + Follow Hal Katz + Follow Jonathan Porter + Follow more less

PUBLISH YOUR CONTENT ON JD SUPRA

• ✔ Increased readership
• ✔ Actionable analytics
• ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra

Start Publishing »

Published In:

Acquisitions + Follow Ambulatory Surgery Centers + Follow Audits + Follow Buyers + Follow Compensation & Benefits + Follow Compliance + Follow Compliance Monitoring + Follow Due Diligence + Follow Health Care Providers + Follow Healthcare + Follow Incentives + Follow Mergers + Follow Physician Compensation Arrangements + Follow Physicians + Follow Risk Management + Follow General Business + Follow Health + Follow Mergers & Acquisitions + Follow more less

Husch Blackwell LLP on:

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide